Reuters logo
BRIEF-RaQualia Pharma ends license agreement related to EP4 antagonist
November 29, 2017 / 6:42 AM / 18 days ago

BRIEF-RaQualia Pharma ends license agreement related to EP4 antagonist

Nov 29 (Reuters) - RaQualia Pharma Inc

* Says it ends license agreement with Maruishi Pharmaceutical Co Ltd regarding EP4 antagonist

Source text in Japanese:goo.gl/CxExhq

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below